MSOS:NYE-AdvisorShares Pure US Cannabis ETF (USD)

ETF | Others |

Last Closing

USD 3.43

Change

-0.14 (-3.92)%

Market Cap

USD 0.45B

Volume

7.24M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.01 (+0.05%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.11 (+0.19%)

USD 38.71B
DFAC Dimensional U.S. Core Equity 2..

+0.01 (+0.03%)

USD 33.57B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 32.29B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 28.80B
DTB DTE Energy Company 2020 Series

-0.01 (-0.05%)

USD 26.58B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 19.74B
GBTC Grayscale Bitcoin Trust (BTC)

-1.69 (-2.19%)

USD 19.50B
AVUV Avantis® U.S. Small Cap Value..

+0.38 (+0.39%)

USD 16.10B
CGDV Capital Group Dividend Value E..

+0.11 (+0.30%)

USD 13.61B

ETFs Containing MSOS

YOLO AdvisorShares Pure Cannab.. 35.05 % 0.00 %

-0.06 (0%)

USD 0.03B
BUDX 23.56 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.97% 4% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.97% 3% F 6% D-
Trailing 12 Months  
Capital Gain -60.02% 1% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -60.02% 1% F 2% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -23.79% 1% F 2% F
Dividend Return -23.79% 1% F 2% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.81% 5% F 23% F
Risk Adjusted Return -56.89% 4% F 3% F
Market Capitalization 0.45B 82% B 47% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.